NCT04471792View on ClinicalTrials.gov

Creatine Use and Muscle Stretching in Peripheral Artery Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Creatine monohydrate

Creatine monohydrate will be used in combination with muscle stretching.

DIETARY_SUPPLEMENT

Cellulose

Cellulose will be used in combination with muscle stretching.

Trial Locations (1)

32304

Florida State University, Tallahassee

All Listed Sponsors
lead

Florida State University

OTHER

NCT04471792 - Creatine Use and Muscle Stretching in Peripheral Artery Disease | Biotech Hunter | Biotech Hunter